BIB Seed Capital

We are a holding involved in bio-med-tech-IT area.

read more

History

BIB Seed Capital is involved in commecial exploitation of the scientific and technological achievements of Polish scientists, promotion of the transfer of technologies from Polish scientific units to small and medium-sized companies that operate in Poland.

Biotechnology and
molecular biology

Projects related to obtaining specialized enzymes and hormones, development of bioinformatics products and services.

Pharmaceutical
chemistry

Projects related to obtaining specialized chemical substances, including catalysts, preparing documentation as well as obtaining and production of generic medicines, specialized feed components, or plant care substances.

Other projects
spanning multiple fields

that are realized at the edge of medicine, biology, chemistry, physics and informatics.

Objectives

Our objective is building an effective cooperation model between the spheres of science and business, leading to long-term mutual benefits.

BIB Seed Capital uses various methods of acquiring. Among others we cooperate with:
  • university and PAN partners;
  • cooperate with technology parks;
  • actively monitor of scientific environments for R&D projects;

Projects

Team

Marcin Hoffmann

Marcin Hoffmann

CEO

Professor of Chemistry, graduated from biotechnology studies at the Biology Department of UAM, in 2000 MBA (Georgia State University Atlanta and the Economic Academy in Poznań). In the years 2001-2002 he was awarded a shcholarship from the Foundation for Polish Science to study with Keiji Morokuma at the University of Emory in Atlanta. He studies molecular recognition and reaction mechanisms. He studies effects of fluorine atom introduction into chemical compounds; mechanisms of reactions catalysed by transition metal complexes.

In the years 2002-2003 he worked as a consultant in McKinsey & Co in Warsaw, where he participated in projects related to the telecommunications sector and energy carriers.

Since 2004 he has been involved in BioInfoBank. He was responsible for running the part of the company that was dedicated to investing in newly created innovative companies.

Thanks to his scientific and business experience, he can efficiently communicate with scientists and businessmen alike and has the knowledge and experience related to the needs of the commercial utilization of scientific research from the innovative solution creation stage by evaluating its commercial potential, formulating the product strategy, organizing an innovative company and its development.

Leszek Rychlewski

Leszek Rychlewski

President of Supervisory Board

Graduated from medical school in Berlin and later worked in San Diego, where he conducted bioinformatics research. In 200 he returned to Poland, where he conducted bioinformatics research in the International Institute of Molecular Biology. He has co- authored over 100 scientific papers.

He was the founder of BioInfoBank, as well as Instytut BioInfoBank, which conducts research in the field of bioinformatics. He organizes cooperation between researchers and businesses (he was, among others, the coordinator of the Center of Excellence CITech (Center for Innovative Technologies) which cooperated with scientific laboratories and bioinformatics enterprises).

He has realized and numerous projects of the European Commission-funded 5th, 6th and7th Program for the total value of over 20 million euro (including the budget of the European partners). His scientific and business experience allow L. Rychlewski to possess extensive knowledge on topics related to development and functioning of innovative bioinformatics enterprises in Poland.

Contact

BIB Seed Capital is in the Poznań Regional Court enterprise registry, VIII WG KRS, no. 0000379911

BIB Seed Capital s.a.

ul. Św. Marcin 80/82 lok. 355

61-809 Poznań

tel/fax: (+48 61) 852 49 46


e-mail: seed@bioinfo.pl


NIP: 972 115 67 19

Regon: 300574097